Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > ANALYST REPORTS ON CXR - TARGET PRICE CHANGES
View:
Post by marcrobert on Aug 15, 2016 12:21pm

ANALYST REPORTS ON CXR - TARGET PRICE CHANGES

Anyone who has access to any updates since Friday please COPY and paste here. NO LINKS - nobody can access links that require login,
Comment by LatticelnExile on Aug 15, 2016 12:33pm
This post has been removed in accordance with Community Policy
Comment by visionaryfool on Aug 15, 2016 12:37pm
$9 USD or CAD?
Comment by LatticelnExile on Aug 15, 2016 12:47pm
This post has been removed in accordance with Community Policy
Comment by fillipinophil on Aug 15, 2016 12:42pm
         Sector: Biotech & Pharma, Healthcare         August 15, 2016 Concordia International Corp. Q2/16 Results – Guidance Lowered Due to FX, Legacy Business Our view: Although we had recently revised our forecasts to reflect FX impact post-Brexit and weakness in the U.S. legacy business, our revisions were not significant ...more  
Comment by fillipinophil on Aug 15, 2016 12:44pm
Sorry this was posted in error,,,,,,
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities